Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk

被引:30
|
作者
Tuettelmann, Frank [1 ,2 ,3 ]
Ivanov, Petar [4 ,5 ]
Dietzel, Charlotte [1 ,2 ,3 ]
Sofroniou, Anna [1 ,2 ,3 ]
Tsvyatkovska, Tsvetomira M. [4 ]
Komsa-Penkova, Regina S. [5 ]
Markoff, Arseni [2 ,3 ,6 ]
Wieacker, Peter [1 ,2 ,3 ]
Bogdanova, Nadja [1 ,2 ,3 ]
机构
[1] Univ Clin Muenster, ZMBE, Inst Human Genet, Munster, Germany
[2] Univ Clin Muenster, IZKF, Munster, Germany
[3] Univ Munster, D-48149 Munster, Germany
[4] Med Univ Pleven, Clin Inst Reprod Med, BU-5800 Pleven, Bulgaria
[5] Med Univ Pleven, Dept Chem & Biochem & Phys & Biophys, BU-5800 Pleven, Bulgaria
[6] Univ Clin Muenster, ZMBE, Inst Med Biochem, Munster, Germany
关键词
M2/ANXA5; ANXA5; annexin A5; recurrent pregnancy loss; risk factor; PLACENTAL ANTICOAGULANT PROTEIN; ANXA5; GENE; COMMON HAPLOTYPE; V EXPRESSION; WOMEN; REDUCTION; CARRIAGE; PROMOTER;
D O I
10.1016/j.fertnstert.2013.06.046
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the influence of M2/ANXA5 for recurrent pregnancy loss (RPL), according to the timing of miscarriages and assess the male partner risk. Design: Genetic association study. Setting: Academic research center. Patient(s): Female patients from two academic centers in Germany and Bulgaria with two or more unexplained miscarriages were selected for this study. Male partners were available for a part of the German sample. Population controls were recruited from healthy individuals of respective populations. Intervention(s): None. Main Outcome Measure(s): Incidence of M2 carriage and odds ratios were calculated between patient and control groups, and RPL risk was evaluated. Result(s): The M2 haplotype in ANXA5 was associated with greater overall RPL risk in German and in Bulgarian women, and a trend of higher prevalence was seen for male partners of German RPL patients. The highest relative risk of M2 carriage was observed in women of both populations with "early'' fetal losses between the 10th and 15th gestational weeks, which was significant in the meta-analysis. Conclusion(s): M2 carriage seems to have an RPL risk role mostly for early abortions, gestational weeks 10-15. In the first phase of pregnancy this correlates with vascular remodeling to accomplish the transition from high-to low-resistance blood vessels. (C) 2013 by American Society for Reproductive Medicine.
引用
收藏
页码:1321 / 1325
页数:5
相关论文
共 26 条
  • [1] Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study
    Rogenhofer, Nina
    Engels, Laura
    Bogdanova, Nadja
    Tuettelmann, Frank
    Markoff, Arseni
    Thaler, Christian
    FERTILITY AND STERILITY, 2012, 98 (02) : 383 - 388
  • [2] Annexin A5 Promoter Haplotype M2 Is Not a Risk Factor for Recurrent Pregnancy Loss in Northern Europe
    Nagirnaja, Liina
    Nommemees, Diana
    Rull, Kristiina
    Christiansen, Ole B.
    Nielsen, Henriette S.
    Laan, Maris
    PLOS ONE, 2015, 10 (07):
  • [3] Annexin A5 haplotype M2 is not a risk factor for recurrent spontaneous abortion in Northern Europe: is there sufficient evidence?
    Markoff, Arseni
    Kurahashi, Hiroki
    Grandone, Elvira
    Bogdanova, Nadja
    REPRODUCTIVE BIOMEDICINE ONLINE, 2016, 32 (05) : 469 - 473
  • [4] Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF)
    Rogenhofer, Nina
    Markoff, Arseni
    Ennerst, Xenia
    Bogdanova, Nadja
    Thaler, Christian
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (01) : 235 - 242
  • [5] Genetic variations and haplotypes in the annexin A5 gene are associated with the risk of recurrent pregnancy loss
    Lan, Yanli
    Wang, Jing
    Zhang, Qinghua
    Yang, Xuezhou
    Li, Lin
    Yin, Jiu
    Li, Hemei
    Song, Xuan
    Chen, Zhilan
    Liu, Yun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 18308 - 18316
  • [6] Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients
    Rogenhofer, Nina
    Engles, Laura
    Bogdanova, Nadja
    Tuettelmann, Frank
    Thaler, Christian J.
    Markoff, Arseni
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (08): : 1057 - 1060
  • [7] Response to "Annexin A5 haplotype M2 is not a risk factor for recurrent miscarriages in Northern Europe, is there sufficient evidence?"
    Nagirnaja, Liina
    Nommemees, Diana
    Rull, Kristiina
    Christiansen, Ole B.
    Nielsen, Henriette S.
    Laan, Maris
    REPRODUCTIVE BIOMEDICINE ONLINE, 2016, 33 (01) : 114 - 115
  • [8] Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism
    Grandone, Elvira
    Tiscia, Giovanni
    Colaizzo, Donatella
    Chinni, Elena
    Pisanelli, Daniela
    Bafunno, Valeria
    Margaglione, Maurizio
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (05) : 461.e1 - 461.e5
  • [9] Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications
    Tiscia, Giovanni
    Colaizzo, Donatella
    Chinni, Elena
    Pisanelli, Daniela
    Scianname, Natale
    Favuzzi, Giovanni
    Margaglione, Maurizio
    Grandone, Elvira
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) : 309 - 313
  • [10] Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5 M2 haplotype
    Fishel, Simon
    Patel, Rashmi
    Lytollis, Alison
    Robinson, Jeanette
    Smedley, Mary
    Smith, Paula
    Cameron, Craig
    Thornton, Simon
    Dowell, Ken
    Atkinson, Glenn
    Shaker, Adel
    Lowe, Philip
    Kazem, Rahnuma
    Brett, Sandra
    Fox, Anna
    REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 29 (01) : 80 - 87